Sequence variation in telomerase reverse transcriptase (TERT) as a determinant of risk of cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study
Open Access
- 23 July 2015
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 16 (1) , 1-10
Abstract
Telomerase reverse transcriptase (TERT) maintains telomere ends during DNA replication by catalyzing the addition of short telomere repeats. The expression of telomerase is normally repressed in somatic cells leading to a gradual shortening of telomeres and cellular senescence with aging. Interindividual variation in leukocyte telomere length has been previously associated with susceptibility to cardiovascular disease. The aim of the present study was to determine whether six variants in the TERT gene are associated with risk of incident coronary heart disease, incident ischemic stroke, and mortality in participants in the biracial population-based Atherosclerosis Risk in Communities (ARIC) study, including rs2736100 that was found to influence mean telomere length in a genome-wide analysis. ARIC is a prospective study of the etiology and natural history of atherosclerosis in 15,792 individuals aged 45 to 64 years at baseline in 1987–1989. Haplotype tagging SNPs in TERT were genotyped using a custom array containing nearly 49,000 SNPs in 2,100 genes associated with cardiovascular and metabolic phenotypes. Cox proportional hazards models were used to assess the association between the TERT polymorphisms and incident cardiovascular disease and mortality over a 20-year follow-up period in 8,907 whites and 3,022 African-Americans with no history of disease at the baseline examination, while individuals with prevalent cardiovascular disease were not excluded from the analyses of mortality. After adjustment for age and gender, and assuming an additive genetic model, rs2736122 and rs2853668 were nominally associated with incident coronary heart disease (hazards rate ratio = 1.20, p = 0.02, 95 % confidence interval = 1.03– 1.40) and stroke (hazards rate ratio = 1.17, p = 0.05, 95 % confidence interval = 1.00 - 1.38), respectively, in African-Americans. None of the variants was significantly associated with cardiovascular disease in white study participants or with mortality in either racial group. Replication in additional population-based samples combined with genotyping of polymorphisms in other genes involved in maintenance of telomere length may help to determine whether genetic variants associated with telomere homeostasis influence the risk of cardiovascular disease in middle-aged adults.Keywords
This publication has 55 references indexed in Scilit:
- Telomere-associated polymorphisms correlate with cardiovascular disease mortality in Caucasian women: The Cardiovascular Health StudyMechanisms of Ageing and Development, 2012
- Genetic variants in eleven telomere-associated genes and the risk of incident cardio/cerebrovascular disease: The Women's Genome Health StudyClinica Chimica Acta, 2011
- Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient miceNature, 2010
- Relative Leukocyte Telomere Length and Risk of Incident Ischemic Stroke in Men: A Prospective, Nested Case-Control ApproachRejuvenation Research, 2010
- Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biologyProceedings of the National Academy of Sciences, 2010
- Association of shorter mean telomere length with risk of incident myocardial infarction: A prospective, nested case–control approachClinica Chimica Acta, 2009
- A second generation human haplotype map of over 3.1 million SNPsNature, 2007
- Telomere length is paternally inherited and is associated with parental lifespanProceedings of the National Academy of Sciences, 2007
- No Gene Is an Island: The Flip-Flop PhenomenonThe American Journal of Human Genetics, 2007
- Telomeres shorten during ageing of human fibroblastsNature, 1990